UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors

    • Categories

    Archives

    Dec

    04

    UCB shares leading scientific research and advances at American Epilepsy Society Annual Meeting

    Read More Share:linkedin| twitter| email| facebook

    Nov

    26

    UCB presents latest scientific research in epilepsy at American Epilepsy Society (AES) Annual Meeting

    Read More Share:linkedin| twitter| email| facebook

    Jun

    20

    UCB Launches Dravet Syndrome Sound of Profound Moments: Family Video Project

    Read More Share:linkedin| twitter| email| facebook

    Apr

    11

    Our Leadership and Legacy in Epilepsy and Rare Syndromes

    Read More Share:linkedin| twitter| email| facebook

    Oct

    04

    UCB presents late-breaking posters at Child Neurology Society Meeting

    Read More Share:linkedin| twitter| email| facebook

    Jun

    02

    Prioritizing Mental Health as a Caregiver to a Child With Dravet Syndrome

    Read More Share:linkedin| twitter| email| facebook

    Apr

    17

    UCB Announces FINTEPLA® (fenfluramine) Oral Solution Is Now Descheduled and Is No Longer Listed as a Controlled Substance

    Read More Share:linkedin| twitter| email| facebook

    Jun

    13

    UCB Builds Partnerships with Rare Epilepsy Syndrome Patient Groups

    Read More Share:linkedin| twitter| email| facebook

    © 2009 - 2025 UCB, Inc. Atlanta. All rights reserved. 
    Last updated: August 2025